These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2350369

  • 1. Vitamin E content and low density lipoprotein oxidizability induced by free radicals.
    Babiy AV, Gebicki JM, Sullivan DR.
    Atherosclerosis; 1990 Apr; 81(3):175-82. PubMed ID: 2350369
    [Abstract] [Full Text] [Related]

  • 2. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation.
    Neuzil J, Thomas SR, Stocker R.
    Free Radic Biol Med; 1997 Apr; 22(1-2):57-71. PubMed ID: 8958130
    [Abstract] [Full Text] [Related]

  • 3. Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation.
    Khalil A, Fortin JP, LeHoux JG, Fülöp T.
    J Lipid Res; 2000 Oct; 41(10):1552-61. PubMed ID: 11013296
    [Abstract] [Full Text] [Related]

  • 4. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach.
    Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U.
    Free Radic Res; 1996 Feb; 24(2):135-47. PubMed ID: 8845914
    [Abstract] [Full Text] [Related]

  • 5. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
    Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I.
    Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
    [Abstract] [Full Text] [Related]

  • 6. Inverse deuterium kinetic isotope effect for peroxidation in human low-density lipoprotein (LDL): a simple test for tocopherol-mediated peroxidation of LDL lipids.
    Witting PK, Bowry VW, Stocker R.
    FEBS Lett; 1995 Nov 13; 375(1-2):45-9. PubMed ID: 7498477
    [Abstract] [Full Text] [Related]

  • 7. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
    Fuhrman B, Volkova N, Rosenblat M, Aviram M.
    Antioxid Redox Signal; 2000 Nov 13; 2(3):491-506. PubMed ID: 11229363
    [Abstract] [Full Text] [Related]

  • 8. Role of alpha-tocopheroxyl radical in the initiation of lipid peroxidation in human low-density lipoprotein exposed to horse radish peroxidase.
    Witting PK, Upston JM, Stocker R.
    Biochemistry; 1997 Feb 11; 36(6):1251-8. PubMed ID: 9063873
    [Abstract] [Full Text] [Related]

  • 9. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins.
    Suarna C, Hood RL, Dean RT, Stocker R.
    Biochim Biophys Acta; 1993 Feb 24; 1166(2-3):163-70. PubMed ID: 8443232
    [Abstract] [Full Text] [Related]

  • 10. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation.
    Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H.
    J Lipid Res; 1991 Aug 24; 32(8):1325-32. PubMed ID: 1770314
    [Abstract] [Full Text] [Related]

  • 11. Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification.
    Suzukawa M, Ishikawa T, Yoshida H, Nakamura H.
    J Am Coll Nutr; 1995 Feb 24; 14(1):46-52. PubMed ID: 7706609
    [Abstract] [Full Text] [Related]

  • 12. Cholesterylester hydroperoxide reducing activity associated with isolated high- and low-density lipoproteins.
    Sattler W, Christison J, Stocker R.
    Free Radic Biol Med; 1995 Mar 24; 18(3):421-9. PubMed ID: 9101232
    [Abstract] [Full Text] [Related]

  • 13. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C, Postiglione A, Triggiani M, Corso G, Palumbo G, Carbone V, Ruocco A, Ambrosio G, Montefusco S, Malorni A, Condorelli M, Chiariello M.
    Atherosclerosis; 1995 Dec 24; 118(2):259-73. PubMed ID: 8770320
    [Abstract] [Full Text] [Related]

  • 14. Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice: apoE-/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis.
    Neuzil J, Christison JK, Iheanacho E, Fragonas JC, Zammit V, Hunt NH, Stocker R.
    J Lipid Res; 1998 Feb 24; 39(2):354-68. PubMed ID: 9507996
    [Abstract] [Full Text] [Related]

  • 15. Oxidation resistance of LDL is correlated with vitamin E status in beta-thalassemia intermedia.
    Tesoriere L, D'Arpa D, Maggio A, Giaccone V, Pedone E, Livrea MA.
    Atherosclerosis; 1998 Apr 24; 137(2):429-35. PubMed ID: 9622286
    [Abstract] [Full Text] [Related]

  • 16. Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease.
    Karmansky I, Shnaider H, Palant A, Gruener N.
    Clin Biochem; 1996 Dec 24; 29(6):573-9. PubMed ID: 8939406
    [Abstract] [Full Text] [Related]

  • 17. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol.
    Stocker R, Bowry VW, Frei B.
    Proc Natl Acad Sci U S A; 1991 Mar 01; 88(5):1646-50. PubMed ID: 2000375
    [Abstract] [Full Text] [Related]

  • 18. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE.
    Diabetes Nutr Metab; 2001 Feb 01; 14(1):27-36. PubMed ID: 11345163
    [Abstract] [Full Text] [Related]

  • 19. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
    Porkkala-Sarataho E, Nyyssönen K, Salonen JT.
    Atherosclerosis; 1996 Jul 01; 124(1):83-94. PubMed ID: 8800496
    [Abstract] [Full Text] [Related]

  • 20. Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.
    Babiy AV, Gebicki JM, Sullivan DR, Willey K.
    Biochem Pharmacol; 1992 Mar 03; 43(5):995-1000. PubMed ID: 1554398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.